Related Experiment Videos

Monosodium glutamate and asthma

D D Stevenson1

  • 1Division of Allergy, Asthma and Immunology, Scripps Clinic and the Scripps Research Institute, La Jolla, CA 92037, USA.

Insights

Monosodium glutamate (MSG) challenges in asthmatic patients show inconsistent results. Rigorous studies indicate no conclusive evidence of MSG-induced asthma, even in those with a history of reactions.

Area of Science:

  • Clinical Medicine
  • Allergy and Immunology
  • Pulmonary Medicine

Background:

  • Monosodium glutamate (MSG) has been anecdotally linked to asthma exacerbations.
  • Previous studies reported positive MSG challenges in asthmatic individuals.

Purpose of the Study:

  • To evaluate the evidence for MSG-induced asthma.
  • To critically assess studies reporting positive MSG challenges versus those with negative findings.

Main Methods:

  • Review and analysis of existing studies on MSG challenges in asthmatic volunteers.
  • Comparison of methodologies in studies reporting positive versus negative MSG challenge results.
  • Statistical analysis including confidence intervals for MSG-naive and MSG-history-positive asthmatics.

Main Results:

  • Two early studies reported positive MSG challenges, but four subsequent, more rigorous studies found no reactions in 45 MSG-history-positive asthmatics.
  • No reactions were observed in 109 asthmatic patients without a history of MSG sensitivity.
  • Methodological flaws were identified in the studies reporting positive MSG challenges.

Conclusions:

  • The existence of MSG-induced asthma is not conclusively established, even in patients with a history of reactions.
  • Methodological differences may explain discrepancies in study outcomes.
  • Further high-quality research is needed to definitively ascertain the role of MSG in asthma.

Related Concept Videos